An op-ed by Dean J. Paranicas, HINJ President and Chief Executive Officer
February 19, 2021 ― Medical innovation in the U.S. is at an inflection point. The breathtaking achievements of our life sciences community in tacking the COVID-19 pandemic further the industry’s legacy of its capacity to respond quickly to health crises.
